Board meeting scheduled for May 27, 2026, to approve audited standalone and consolidated financial results for Q4 and FY ending March 31, 2026.
Agenda includes consideration and recommendation of dividend on equity shares for the financial year ended March 31, 2026.
Trading window for designated persons remains closed from April 1, 2026, to May 29, 2026, inclusive, due to insider trading regulations.